Role of Concomitant Chemo radiotherapy in Advanced Head & Neck Cancer.

Authors

  • M HAFEEZ
  • SHAHARYAR ,
  • K SHABBIR
  • M FAROOQ
  • Z ALAUDDIN
  • E U REHMAN

DOI:

https://doi.org/10.21649/akemu.v11i2.4252

Keywords:

Concomitant chemo-radio therapy, head and neck.

Abstract

A prospective study was conducted at Clinical Oncology Department K.E Medical College/Mayo Hospital, Lahore from March, 2003 to February 2004 to evaluate the response in 25 eligible advanced irresectable head and neck cancer patients treated with concomitant chemo-radiotherapy. Male patients were 18(72%) in number and female were 7(28%). T2 lesions were treated with a total dose of 6500 cGy while T3 and T4 lesions were given a dose of 6500 - 7500 cGy in conventional fractions. Single agent, cisplatin (100 mg/m2) was given with radiation therapy. Thirteen (52%) patients had a complete response and 9 (36%) patients had partial response. Concomitant chemo-radiation therapy is a better option for irresectable stage III and IV head and neck cancers with manageable toxicities (Grade III and IV) in majority of the patients.

Published

2021-01-23

How to Cite

HAFEEZ, M. ., , S., SHABBIR, K. ., FAROOQ, M. ., ALAUDDIN, Z. ., & REHMAN, E. U. . (2021). Role of Concomitant Chemo radiotherapy in Advanced Head & Neck Cancer. Annals of King Edward Medical University, 11(2), 100-101. https://doi.org/10.21649/akemu.v11i2.4252

Issue

Section

Articles

Most read articles by the same author(s)

> >>